PDA TR 55 PDF

PDA TR 55 PDF

Name:
PDA TR 55 PDF

Published Date:
03/01/2012

Status:
Active

Description:

Technical Report No. 55 (TR 55) Detection and Mitigation of 2,4,6-Tribromoanisole and 2,4,6-Trichloroanisole Taints and Odors in the Pharmaceutical and Consumer Healthcare Industries

Publisher:
Parenteral Drug Association

Document status:
Active

Format:
Electronic (PDF)

Delivery time:
10 minutes

Delivery time (for Russian version):
200 business days

SKU:

Choose Document Language:
$97.5
Need Help?
This PDA technical report provides guidance on how to detect and mitigate TBA and TCA odors and taints. Well recognized in the food and beverage industries, the literature features knowledge from these industries regarding the origin of these odors and taints, analytical methods developed, and risk management strategies employed. In 2009, this became an issue for the pharmaceutical and consumer healthcare industries with product recalls from four companies due to the risk of product exposure to the TBA taint from tribromophenol-treated wood pallets. Recalls from additional firms continued through 2011. The TBA/TCA Task Force worked very rapidly in response to the pressing need within industry for guidance on this topic. Formed at the end of 2010, the group drafted one of the most comprehensive technical reports in PDA's library in record time. This report provides background on issues with TBA and TCA taints, highlighting:
  • Uses of 2,4,6-tribromophenol (TBP) and 2,4,6-trichlorophenol (TCP) in industry
  • Role of fungal halophenol methylation that generates TBA and TCA haloanisole taints
  • Sensory and physiochemical properties of TBP, TCP, TBA and TCA
  • Case examples from food and beverage industries with root causes and remedial actions
  • Recent examples of TBA taint recalls from the pharmaceutical and consumer healthcare industries
Additionally, this report offers guidance on signal detection from adverse event and/or product quality complaints and resulting recalls, toxicology and safety, analytical method development and use, supply chain controls, risk analysis and mitigation. Definitions of technical terms used in this report can be found in the glossary. The principles and tools used to manage these taints are also defined in this report.
File Size : 1 file , 2.5 MB
ISBN(s) : 9780939459391
Number of Pages : 91
Product Code(s) : 01055
Published : 03/01/2012

History


Related products

PDA TR 13
Published Date: 04/22/2022
Technical Report 13 Revised 2022, (TR 13) Fundamentals of an Environmental Monitoring Program
$97.5
PDA TR 52
Published Date: 08/01/2011
Technical Report No. 52 (TR 52) Guidance for Good Distribution Practices (GDPs) For the Pharmaceutical Supply Chain
$97.5
PDA TR 64
Published Date: 10/01/2013
Technical Report No. 64 (TR 64) Active Temperature-Controlled Systems: Qualification Guidance
$97.5
PDA TR 69
Published Date: 06/01/2015
Technical Report No. 69 (TR 69) Bioburden and Biofilm Management in Pharmaceutical Manufacturing Operations
$97.5

Best-Selling Products

HIMSS/NEMA HN 1-2008
Published Date:
Manufacturer Disclosure Statement for Medical Device Security
HIMSS/NEMA HN 1-2013
Published Date: 11/01/2013
Manufacturer Disclosure Statement for Medical Device Security
Free Download